Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.26.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
REVENUES $ 1,081 $ 643 $ 3,171 $ 2,305
COST OF REVENUES 650 460 1,926 1,566
GROSS PROFIT 431 183 1,245 739
OPERATING EXPENSES:        
Research and development expenses 616 591 1,963 1,947
Sales and marketing expenses 600 789 2,041 2,155
General and administrative expenses 693 805 2,164 2,224
Other income (73) (73)
TOTAL OPERATING EXPENSES 1,909 2,112 6,168 6,253
OPERATING LOSS (1,478) (1,929) (4,923) (5,514)
Interest expense (12) (27) (132) (83)
Other financial income (expense), net 243 (24) (41) (144)
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (1,247) $ (1,980) $ (5,096) $ (5,741)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.04) $ (1.68) $ (0.21) $ (5.84)
Net loss per share attributable to common shareholders – diluted (in Dollars per share) $ (0.04) $ (1.68) $ (0.21) $ (5.84)
Weighted average shares of common stock used in computing net loss per share – basic (in Shares) 32,691,034 1,178,762 24,846,478 982,487
Weighted average shares of common stock used in computing net loss per share – diluted (in Shares) 32,691,034 1,178,762 24,846,478 982,487